Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat

Synapse

Volumn 49, Issue 1, 2003, Pages 1-11

  Olds, M E ^a   Jacques, D B ^b   Kpoyov, O ^b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b NEUROSCIENCES INSTITUTE   (United States)

Author keywords

Cytotoxic lesion; Dopamine; Entopeduncular nucleus; Subthalamic nucleus; Transplant

Indexed keywords

AMPHETAMINE; APOMORPHINE; OXIDOPAMINE; QUINOLINIC ACID;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN ELECTROPHYSIOLOGY; BRAIN INJURY; BRAIN REGION; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; DRUG MECHANISM; ELECTROPHYSIOLOGY; ENTOPEDUNCULAR NUCLEUS; EVOKED RESPONSE; FETUS (ANATOMY); HEMISPHERE; MALE; MESENCEPHALON; MOTOR ACTIVITY; MOTOR PERFORMANCE; NERVE CELL; NERVE CELL EXCITABILITY; NEUROPHYSIOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEREOTYPY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TISSUE TRANSPLANTATION;

AMPHETAMINE; ANIMALS; APOMORPHINE; BRAIN DISEASES; BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; ELECTROPHYSIOLOGY; ENTOPEDUNCULAR NUCLEUS; FETAL TISSUE TRANSPLANTATION; FETUS; FUNCTIONAL LATERALITY; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; MODELS, ANIMAL; MOTOR ACTIVITY; NEURONS; PARKINSON DISEASE; QUINOLINIC ACID; RATS; TYROSINE 3-MONOOXYGENASE;

EID: 0038475864     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10208     Document Type: Article

References (34)

1. Albin RL, Young AB, Penny JB. 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
2. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. 1991. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 6:288-292.
3. Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B. 1993. Reversal of rigidity and improvement in motor performance by subthalamic high frequency stimulation in MPTP-treated monkeys. Eur J Neurosci 5:382-389.
4. Bergman H, Wichmann T, Delong MR. 1990. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436-1438.
5. Bjorklund A, Stenevi U. 1979. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560.
6. Chesselet MF, Delfs JM. 1996. Basal ganglia and movement disorders: an update. TINS 19:416-422.
7. Dawson TM, Dawson VL, Gage FH, Fisher LJ, Hunt MA, Wamsley JK. 1991. Functional recovery of supersensitive DA receptors after intrastriatal grafts of fetal substantia nigra. Exp Neurol 111:282-292.
8. DeLong MR. 1990. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
9. DiFiglia M. 1990. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci 13:286-289.
10. Dunnett SB, Bjorklund A, Stenevi U, Iversen SD. 1981. Grafts of embryonic substantia nigra innervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res 229:209-217.
11. Dunnett SB, Bjorklund A, Schmidt RH, Stenevi U, Iversen SD. 1983. Intracerebral grafting of neuronal cell suspensions. IV. Behavioral recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different brain sites. Acta Physiol Scand Suppl 522:29-37.
12. Fernandez PM, Dujovny M. 1997. Pallidotomy. Neurol Res 19,1:25-34.
13. Freed WJ, Perlow MJ, Karoum F, Serger A, Olson L, Hoffer BJ. 1980. Restoration of dopaminergic function by grafting of fetal substantia nigra to the caudate nucleus: long-term behavioral, biochemical and histochemical studies. Ann Neurol 8:510-519.
14. Gaucher S, Mayer A, Yougman S. 1997. The effect of nigra implantation on sensitization to dopamine agonists in 6-hydroxydopamine-lesioned rats. Neuroscience 79:963-972.
15. Iversen SD. 1977. Brain dopamine systems and behavior. In: Iversen LL, Iversen SD, Snyder SH, editors. Drugs, neurotransmitters and behavior. In: Handbook of psychopharmacology, 8. New York: Plenum Press. p 333-384.
16. Joel D, Ayalon L, Tarrasch R, Veenman L, Feldon J, Weiner I. 1998. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease. Brain Res 787:143-148.
17. Kreiss DS, Mastropietro CW, Raw JI, Walters JR. 1997. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 17:6807-6819.
18. Laitinen LV, Bergenheim AT, Hariz MI. 1992. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76:53-61.
19. Martin JB. 1986. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171.
20. Olanow CW, Kordower JH, Freeman TB. 1996. Fetal nigral transplantation as a therapy for Parkinson's disease. TINS 19:102-109.
21. Olds J. 1973. Multiple unit recordings from behaving rats. In: Bioelectric recording techniques part A. Cellular processes and brain potentials. New York: Academic Press. p 165-198.
22. Olds ME. 1988. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine. Neuroscience 24:465-476.
23. Olds ME. 1991. Hyperactivity induced by enhanced dopamine activity in accumbens is correlated with increased output by non-dopamine neurons in ventral tegmentum and substantia nigra. Physiol Behav 51:39-50.
24. Olds ME, Jacques DB, Kopyov O. 1998. Globus pallidus lesions depress the excitatory responses to apomorphine but not amphetamine in the subthalamic nucleus of the behaving rat with a 6-OHDA nigra lesion. Brain Res 812:50-64.
25. Olds ME, Jacques DB, Kopyov O. 1999. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra. Synapse 34:228-240.
26. Olds ME, Jacques DB, Kopyov O. 2003. Behavioral and subthalamic effects of combining a fetal ventral mesencephalic transplant in striatum with an electrolytic lesion of the entopeduncular nucleus in the rat with a unilateral 6-OHDA lesion of substantia nigra. Synapse (in press).
27. Parent A, Hazrati L. 1995. Functional anatomy of the basal ganglia. II. The place of the subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 20:128-154.
28. Paxinos G, Watson C. 1983. The rat brain in stereotaxic coordinates. New York: Academic Press.
29. Pycock CJ. 1980. Turning behavior in animals. Neuroscience 5:461-514.
30. Rioux L, Gaudin DP, Gagnon C, Di Paoli T, Bedard PJ. 1991. Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants. Neuroscience 44:75-83.
31. Stone TW. 2001. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Progr Neurobiol 64:185-218.
32. Strick P. 1976. Anatomical analysis of the ventrolateral thalamic input to primate motor cortex. J Neurophysiol 39:1020-1031.
33. Ungerstedt U. 1971a. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior. Acta Physiol Scand Suppl 367:49-68.
34. Ungerstedt U. 1971b. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69-93.